273 results on '"Deedwania, Prakash"'
Search Results
2. MORTALITY IN HEART FAILURE WITH INDETERMINATE KIDNEY DISEASE
3. Imaging Modality for Left Ventricular Ejection Fraction Estimation and Effect of Implantable Cardioverter Defibrillator on Mortality in Patients with Heart Failure
4. Risk of Stroke in Older Adults With Heart Failure
5. Initiation of anti-hypertensive drugs and outcomes in patients with heart failure with preserved ejection fraction and persistent hypertension
6. Initiation of Anti-Hypertensive Drugs and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction
7. Beta-Blocker Use and Outcomes in Nursing Home Residents with Heart Failure with Reduced Ejection Fraction
8. Income disparity and incident cardiovascular disease in older Americans
9. RENIN-ANGIOTENSIN SYSTEM (RAS) INHIBITION IS ASSOCIATED WITH IMPROVED CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) AND ADVANCED KIDNEY DISEASE
10. PROLONGED CARDIOVASCULAR RISK AFTER ≥15 YEARS SMOKING CESSATION IN OLDER FORMER SMOKERS
11. OUTCOME DIFFERENCES BETWEEN PREVALENT USERS VS. NEW USERS OF THE SAME DRUG: WHEN DRUG EFFECT OR SELECTION BIAS CANNOT EXPLAIN POOR OUTCOMES AMONG PREVALENT USERS
12. In-Hospital Weight Loss and Outcomes in Patients with Heart Failure
13. Cardiovascular Impact of Race and Ethnicity in Patients With Diabetes and Obesity
14. A Comprehensive Cardiovascular-Renal-Metabolic Risk Reduction Approach to Patients with Type 2 Diabetes Mellitus
15. Right Ventricular Ejection Fraction and Beta-Blocker Effect in Heart Failure with Reduced Ejection Fraction
16. Loop Diuretic Prescription and Long-Term Outcomes in Heart Failure: Association Modification by Congestion
17. Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension
18. Trends of Cardiac Complications in Patients With Rheumatoid Arthritis: Analysis of the United States National Inpatient Sample; 2005-2014
19. Aspirin for Primary Prevention of Coronary Artery Disease
20. Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation
21. Association between depression and readmission of heart failure: A national representative database study
22. Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure
23. LOW INCOME IS LINKED TO A HIGHER RISK OF MORTALITY AND INCIDENT CARDIOVASCULAR (CV) EVENTS IN OLDER ADULTS: A 23-YEAR FOLLOW-UP OF CARDIOVASCULAR HEALTH STUDY (CHS)
24. INITIATION OF ANTI-HYPERTENSIVE DRUGS AND OUTCOMES IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
25. POOR OUTCOMES ASSOCIATED WITH DIGOXIN DISCONTINUATION IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) MAY DIFFER BY BETA-BLOCKER USE
26. Sodium Glucose Co-transporter 2 Inhibitors and Heart Failure
27. Fish Oil and Cardiometabolic Diseases: Recent Updates and Controversies
28. Therapeutic Inertia in Cardiovascular Disease Prevention
29. An update on pharmacotherapies in diabetic dyslipidemia
30. Emerging strategies for diabetes and cardiovascular disorders: Introduction and foreword
31. Cardiovascular outcome trials of the newer anti-diabetic medications
32. Alirocumab efficacy and safety by race and ethnicity: Analysis from 3 ODYSSEY phase 3 trials
33. SGLT-2 Inhibitors and Peripheral Artery Disease: A Statistical Hoax or Reality?
34. Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial
35. ISOLATED SYSTOLIC HYPERTENSION (ISH) BY NEW ACC/AHA HYPERTENSION (HTN) GUIDELINES AND OUTCOMES IN OLDER ADULTS OVER 23 YEARS IN THE CARDIOVASCULAR HEALTH STUDY (CHS)
36. ADMISSION-TO-DISCHARGE WEIGHT CHANGE AND 30-DAY POST-DISCHARGE OUTCOMES IN OLDER PATIENTS WITH HEART FAILURE WITH PRESERVED AND REDUCED EJECTION FRACTION (HFPEF AND HFREF)
37. EFFICACY AND SAFETY OF LONG-TERM EVOLOCUMAB USE IN ASIAN VERSUS OTHER SUBJECTS: THE FOURIER TRIAL
38. ASSOCIATION OF ATRIAL FIBRILLATION AND OUTCOMES IN OLDER PATIENTS WITH HEART FAILURE WITH PRESERVED AND REDUCED EJECTION FRACTION (HFPEF AND HFREF)
39. Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate
40. 25-Year trends in hypertension prevalence, awareness, treatment, and control in an Indian urban population: Jaipur Heart Watch
41. Dangers of Hypoglycemia in Cardiac Patients With Diabetes
42. Obesity is rarely healthy
43. Dangers and Long-Term Outcomes in Metabolically Healthy Obesity
44. PRIOR HEART FAILURE (HF) HOSPITALIZATION AND 30-DAY AND 1-YEAR OUTCOMES IN PATIENTS WITH HF AND PRESERVED EJECTION FRACTION (HFPEF)
45. HIGH-DOSE BETA-BLOCKERS (BB) AND OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION (HFPEF) AND HEART RATE ≥70 BEATS PER MINUTE (BPM)
46. SECONDHAND SMOKE IS LINKED TO HIGHER RISK OF NON-CARDIOVASCULAR MORTALITY BUT NOT OF CARDIOVASCULAR MORTALITY IN COMMUNITY-DWELLING OLDER ADULTS: FINDINGS FROM CARDIOVASCULAR HEALTH STUDY (CHS)
47. SMOKING AND OUTCOMES IN OLDER PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION (HFPEF)
48. INITIATION OF LOOP DIURETIC THERAPY IS ASSOCIATED WITH A LOWER RISK OF 30-DAY ALL-CAUSE READMISSION IN PATIENTS WITH HEART FAILURE NOT RECEIVING DIURETICS PRIOR TO HOSPITALIZATION
49. ASSOCIATIONS OF SYSTOLIC BLOOD PRESSURE (SBP) <120 (VERSUS 120-139) MMHG WITH OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION (HFPEF) WITHOUT HYPERTENSION (HTN)
50. Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.